Are placebo-controlled studies necessary for efficacy evidence of antidepressants?;Sind plazebokontrollierte studien zum wirksamkeitsbeweis von antidepressiva notwendig?

Nervenarzt

Volumn 75, Issue 5, 2004, Pages 421-424

  Moller H J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESEARCH; EDITORIAL; HUMAN; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ANTIDEPRESSIVE AGENTS; CONTROLLED CLINICAL TRIALS; DRUG EVALUATION; EVIDENCE-BASED MEDICINE; HUMANS; PLACEBOS;

EID: 2642566700     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1690-y     Document Type: Editorial

References (3)

1. Baldwin D, Broich K, Fritze J et al. (2004) Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci (in press)
2. Fritze J, Möller HJ (2001) Design of clinical trials of anti-depressants. Should a placebo control arm be included? CNS Drugs 15(10):755-764
3. Fritze J, Gastpar M, Möller HJ (2000) Relevanz von Plazebo zur Kontrolle von Fehlerquellen beim Wirksamkeitsnachweis. In: Maier W, Engel RR, Möller HJ (Hrsg) Methodik von Verlaufs- und Therapiestudien in Psychiatrie und Psychotherapie. Hogrefe, Göttingen, pp 70-82